Methylnaltrexone bromide: Clinical Trials

8 trials of Methylnaltrexone bromide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 recruiting, 1 unknown, 1 withdrawn. 3 Phase 2, 2 Not applicable, 2 Phase 3, 1 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Withdrawn 1
Not applicable2Completed 1, Recruiting 1
Phase 32Unknown 1, Withdrawn 1
Phase 11Completed 1
Phase 41Completed 1

Follow Methylnaltrexone bromide: new trials by email Literature Review of Methylnaltrexone bromide trials Research Report on Methylnaltrexone bromide

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Chronic Widespread Pain in HIV: Novel Mechanisms and Therapeutics
Relistor Injectable Product - Chronic Widespread Pain
Not applicableRecruitingFlorida International University2002021-11-152026-09-11
A Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic Cancer
Methylnaltrexone bromide, Placebo - Pancreatic Cancer
Phase 2 / Phase 3WithdrawnBausch Health Americas, Inc.2020-01-062021-05-07
The Effect of Naloxone and Methylnaltrexone on Esophageal Sensitivity in Health
Naloxone, Methylnaltrexone Bromide, Placebo - Endogenous and Esophageal Sensitivity
Not applicableCompletedUniversitaire Ziekenhuizen KU Leuven122013-10-012017-01-09
Evaluate the Pharmacokinetics (PK) of Methylnaltrexone (MNTX) in Healthy Adult Subjects
Methylnaltrexone bromide - Healthy Adult Subjects
Phase 1CompletedBausch Health Americas, Inc.202010-07-012019-11-29
Methylnaltrexone for Treatment of Opiate-Induced Constipation in the Intensive Care Unit
Methylnaltrexone Bromide, Placebo-Normal Saline - Opioid-induced Constipation
Phase 3UnknownSt. John Health System, Michigan802009-12-012010-01-15
Methylnaltrexone for Opioid-induced Constipation in Cancer Patients
Methylnaltrexone bromide - Neoplasms, Constipation
Phase 2CompletedUniversity of Vermont122009-10-012016-02-02
Safety of Subcutaneous Methylnaltrexone for Opioid-Induced Constipation in Patients With Advanced Illness
Methylnaltrexone bromide - Opioid-Induced Constipation
Phase 4CompletedBausch Health Americas, Inc.1562008-07-012018-03-07
Study of Subcutaneous Methylnaltrexone (MNTX) in the Treatment of Opioid-Induced Constipation During Rehabilitation After Orthopedic Procedures
Methylnaltrexone bromide, Placebo - Opioid-induced Constipation
Phase 2CompletedBausch Health Americas, Inc.372007-10-192019-09-04

Conditions studied

Opioid-Induced Constipation (3)  ·  Constipation (2)  ·  Chronic Pain (1)  ·  Gastroesophageal Reflux (1)  ·  Neoplasms (1)  ·  Opioid-Related Disorders (1)  ·  Pancreatic Neoplasms (1)

Sponsors

Bausch Health Americas, Inc. (4)  ·  Florida International University (1)  ·  St. John Health System, Michigan (1)  ·  Universitaire Ziekenhuizen KU Leuven (1)  ·  University of Vermont (1)

Countries

United States (7)  ·  Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Mexico (1)  ·  Portugal (1)  ·  United Kingdom (1)

Top investigators

Bradford A Whitmer, D.O. (1)  ·  Enoch Bortey (1)  ·  Jan Tack, MD, PhD (1)  ·  John Lahey (1)  ·  Lindsey Mathew (1)  ·  Saurabh Aggarwal, MD., PhD (1)  ·  Steven Ades, MD (1)  ·  Tage Ramakrishna, MD (1)

Results publications

PMID 21998076, PMID 27628064